Processa Pharmaceuticals, Inc.
PCSA$8M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaVERO BEACH10 employees
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 2026
Market Overview
Stock performance and key metrics
PCSA News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
PCS12852
Gastroparesis
PCS6422 and capecitabine
Breast Cancer
RX-3117
Metastatic Pancreatic Cancer
PCS499
Necrobiosis Lipoidica
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PCS12852 | Phase 2 | Gastroparesis | - | - |
PCS6422 and capecitabine | Phase 2 | Breast Cancer | - | - |
RX-3117 | Phase 2 | Metastatic Pancreatic Cancer | - | - |
PCS499 | Phase 2 | Necrobiosis Lipoidica | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply